How can past stroke impact lipitor starting levels?

How does a history of stroke change the LDL target when starting Lipitor?

Prior stroke raises cardiovascular risk enough that guidelines drop the recommended LDL goal to below 70 mg/dL. This lower target often means physicians begin atorvastatin at 40 mg or 80 mg daily rather than the 10 mg or 20 mg doses used in primary prevention.

What LDL drop is realistic with the higher starting dose?

A 40 mg dose typically lowers LDL by 45–50 %; an 80 mg dose lowers it 50–55 %. In secondary-prevention patients, this reduction cuts recurrent stroke risk by roughly 20 % over five years when maintained.

Does prior stroke alter liver or muscle safety checks?

Stroke itself does not change the drug’s safety profile, but patients who are older or take interacting medications need the same baseline liver-enzyme and CK checks before the higher dose is started.

Why might some clinicians still choose 20 mg after stroke?

If the patient is very elderly, frail, or already on a moderate CYP3A4 inhibitor, the added muscle-risk of 40–80 mg may outweigh the incremental stroke-prevention benefit, so 20 mg plus ezetimibe or a PCSK9 inhibitor can be used instead.

When does the patent for branded Lipitor expire in the U.S.?

U.S. exclusivity for atorvastatin ended in 2011, and generic versions have been available since then. DrugPatentWatch lists no remaining composition-of-matter or use patents that would block additional generics [1].

[1] DrugPatentWatch.com – Atorvastatin (Lipitor)